Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06597968

Evaluating the Real World Performance of an AI Based Lung Nodule Detection Tool

Performance Estimation of Triaging Artificial Intelligence Based Computer-Aided Detection Algorithm in Routine Chest Radiography

Status
Recruiting
Phase
Study type
Observational
Enrollment
45,991 (estimated)
Sponsor
University Hospitals Cleveland Medical Center · Academic / Other
Sex
All
Age
18 Years – 89 Years
Healthy volunteers
Not accepted

Summary

chest x-rays will be analyzed by AI software for a secondary read of lung nodules. Chest x-rays will either be sent to the AI tool to be read or to radiologists to read. If the image is sent to the AI tool, the AI software will generate a report on if it detects a lung nodule or not. The image will then be sent to a radiologist to determine if there is agreement or disagreement with the AI tool.

Detailed description

The study is a prospective study for measuring the performance of an AI software in detecting lung nodules from chest X-rays. Data collected during the study will be analyzed for study purposes after end date of data collection. There will be two study arms: the control arm and the interventional arm. Control Arm: There will be no interruption to the existing standard of care pathway. Interventional Arm: Use of AI will occur in parallel to the standard of care pathway. Consistent with the control Arm, the radiologists or clinicians interpreting the chest x-ray images will proceed as usual based on the existing standard operating procedures of the study site. In addition, the AI software will function as a second reader; meaning images will be processed by the AI software which will generate a report. In the event that the radiologist and the AI tool do not agree, cases will be reviewed by qualified study team members twice per week.

Conditions

Interventions

TypeNameDescription
DEVICEAI Based CAD Software (qXR-Ln)All x-ray images have already been obtained and will then be run through CAD software for secondary nodule detection

Timeline

Start date
2025-06-24
Primary completion
2026-04-30
Completion
2026-04-30
First posted
2024-09-19
Last updated
2026-01-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06597968. Inclusion in this directory is not an endorsement.